The Action of Methimazole and L -Thyroxine in Radioiodine Therapy: A Prospective Study on the Incidence of Hypothyroidism
Authors:
- Annie Wai-Chee KungAKAnnie Wai-Chee Kung
- Chun-Chung YauCYChun-Chung Yau
- Ashley Chi-Kin ChengACAshley Chi-Kin Cheng
- 1 February 1995
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 5 (1) , 7-12
Abstract
Thiourea drugs have been postulated to possess radioprotective property. We studied the effect of adjunctive antithyroid drugs (ATD) and L-thyroxine (L-T4) on the result of radioiodine (RAI) 131I therapy and determined the incidence of hypothyroidism and relapse of hyperthyroidism. One hundred and fifty-nine patients with Graves' disease were randomized prospectively to receive either RAI alone or adjunctive ATD in a form of block-replacement regimen of methimazole (MMI) plus L-T4 for 6 months. The patients were observed for a mean period of 4.6 (range 2–10) years. The incidence of permanent hypothyroidism was studied and the effect of ATD on iodine kinetics was analyzed. The cumulative incidence of hypothyroidism in the ATD group was significantly lower than the RAI group (p = 0.0009), and the difference is accounted by a reduction of early hypothyroidism within 12 months from 20.2 to 3.7% (p = 0.003). The incidence of late hypothyroidism was similar between the two groups. Treatment with ATD did not affect the one dose cure rate with RAI (61.2 vs 55.5%, p = NS), but the time to achieve euthyroidism was significantly earlier with adjunctive ATD (2 vs 8 weeks, p < 0.02). The incidence of relapse within the first year after one dose was also similar between the two groups (38.7 vs 44.5%,p = NS). Comparing the kinetics of the therapeutic dose with a tracer dose, patients receiving MMI were found to be underdosed by 22% (p = 0.003) and the biological half-life was significantly shortened. We conclude that ATD rendered euthyroidism earlier without compromising the one dose cure rate of RAI. It also reduced the incidence of RAI-induced hypothyroidism by preventing early hypothyroidism. We advocate adjunctive ATD in view of the more liberal prescription of RAI to young patients.Keywords
This publication has 21 references indexed in Scilit:
- Has the Use of Antithyroid Drugs for Graves' Disease Become Obsolete?Thyroid®, 1993
- Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United StatesThyroid®, 1991
- TREATMENT OF HYPERTHYROIDISM WITH RADIOIODINE: ADJUNCTIVE THERAPY WITH ANTITHYROID DRUGS RECONSIDEREDThe Lancet, 1988
- Radioiodine-induced thyroid stormThe American Journal of Medicine, 1983
- 131I treatment of diffuse and nodular toxic goitre with or without antithyroid agentsEuropean Journal of Endocrinology, 1982
- Hypothyroidism After Low-Dose 131I Treatment of HyperthyroidismAnnals of Internal Medicine, 1972
- TREATMENT OF TOXIC NODULAR AND DIFFUSE GOITRE WITH RADIOACTIVE IODINEEuropean Journal of Endocrinology, 1970
- Effect of Pretreatment with Carbimazole in Patients with Thyrotoxicosis Subsequently Treated with Radioactive IodineBMJ, 1969
- Protection of Mice against X-Radiation by ThioureaScience, 1950
- TREATMENT OF HYPERTHYROIDISM WITH THIOUREA AND THIOURACILJAMA, 1943